STAAR Surgical Company (STAA)
Days of sales outstanding (DSO)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | 3.32 | 2.71 | 3.11 | 4.32 | 4.37 | 4.90 | — | — | 5.03 | — | — | — | 4.38 | — | — | — | — | — | — | — | |
| DSO | days | 109.99 | 134.80 | 117.31 | 84.43 | 83.57 | 74.46 | — | — | 72.50 | — | — | — | 83.26 | — | — | — | — | — | — | — |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 3.32
= 109.99
The Days of Sales Outstanding (DSO) for STAAR Surgical Company have fluctuated over the past five quarters, ranging from 72.50 days to 134.80 days. DSO represents the average number of days it takes for the company to collect revenue from its sales.
The trend shows that DSO increased significantly in the quarter ending September 30, 2023, compared to the quarter ending June 30, 2023. This could indicate potential issues with accounts receivable management and collection efficiency during that period.
Overall, it is essential for STAAR Surgical Company to monitor and manage its DSO closely to ensure effective credit control and timely collections, which can positively impact cash flow and working capital management.
Peer comparison
Dec 31, 2023